You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026
Filter Results
Select search scope: search across all journals or within the current journal
Search this journal
Enter search terms…
/
You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026
Select search scope: search across all journals or within the current journal
Kidney Cancer is an international multidisciplinary journal to facilitate progress in understanding the epidemiology/etiology, genetics, molecular correlates, pathogenesis, pharmacology, ethics, patient advocacy and survivorship, diagnosis and treatment of tumors of the kidney. The journal publishes research reports, reviews, short communications, and letters-to-the-editor.
The journal is dedicated to providing an open forum for original research in basic science, translational research and clinical medicine that will expedite our fundamental understanding and improve treatment of tumors of the kidney.
Effective January 1, 2026, Kidney Cancer will transition from a fully Open Access model to a hybrid publishing model. While select articles will continue to be published Open Access, the majority of content will be available through institutional or individual subscriptions.
To continue accessing the full breadth of research published in Kidney Cancer, we encourage you to recommend the journal to your institution’s library. You can do so using our Library Recommendation Form, by contacting your librarian directly, or emailing sales@liebertpub.com.
Your support helps ensure that the journal remains a trusted resource for advancing scholarship in kidney care and research.
Submit your manuscript today at https://mc.manuscriptcentral.com/kca.